Barry_Bloom

Barry Bloom

Barry Bloom

American immunologist (born 1937)

Barry R. Bloom is Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health in the Department of Immunology and Infectious Diseases and Department of Global Health and Population in the Harvard T.H. Chan School of Public Health in Boston, where he served as dean of the faculty from 1998 through December 31, 2008.

Quick Facts Education, Alma mater ...

As dean, he served as secretary treasurer for the Association of Schools of Public Health. Prior to that he served as chairman of the Department of Microbiology and Immunology at the Albert Einstein College of Medicine from 1978 to 1990, the year in which he became an investigator of the Howard Hughes Medical Institute, where he also served on the national advisory board. In 1978, he was a consultant to the White House on international health policy.

Education

Early life

Bloom notes that the influence of the numerous physicians in his family led him to believe that he would eventually become a physician practicing clinical medical.[1]

Career

Bloom has been a leading scientist in various areas of infectious diseases, vaccines, and global health, and is a former consultant to the White House. Most of his research has been as the principal investigator of a laboratory researching the immune response to tuberculosis, a disease that claims more than 1.5 million lives each year.[2]

For more than 40 years, he has been extensively involved with the World Health Organization. He is currently chair of their Technical and Research Advisory Committee to the Global Programme on Malaria. He has also been a member of their Advisory Committee on Health Research, and chaired their Committees on Leprosy Research and Tuberculosis Research and the Scientific and Technical Advisory Committee of the United Nations Development Programme/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases. Bloom serves on the editorial board of the Bulletin of the World Health Organization.

Bloom currently serves on the Ellison Medical Foundation scientific advisory board and the Wellcome Trust Pathogens, Immunology and Population Health Strategy Committee. He is on the scientific advisory board of the Earth Institute at Columbia University and the advisory council of the Paul G. Rogers Society for Global Health Research.

His past service includes membership on the national advisory council of the National Institute of Allergy and Infectious Diseases, the scientific advisory board of the National Center for Infectious Diseases of the Centers for Disease Control and Prevention, and the national advisory board of the Fogarty International Center at the National Institutes of Health, as well as the governing board of the Institute of Medicine.

Bloom was the founding chair of the board of trustees for the International Vaccine Institute in South Korea, which is devoted to promoting vaccine development for children in the developing world. He has chaired the Vaccine Advisory Committee of the Joint United Nations Programme on HIV/AIDS, better known as UNAIDS, where he played a critical role in the debate surrounding the ethics of AIDS vaccine trials. He was also a member of the US AIDS Research Committee. He serves on the board of the US-China Health Summit.[3]

Bloom has offered expert analysis on the Covid-19 pandemic[4] and in the fall of 2020 was asked to serve on the Massachusetts state advisory committee on coronavirus vaccines.[5]

Current research

Dr. Bloom researches the mechanisms of immune protection against tuberculosis, as an investigator in a Bill and Melinda Gates Grand Challenge grant[6][7] with Professor David Edwards the Harvard John A. Paulson School of Engineering and Applied Sciences, where they study nanoparticle technology to deliver needle-free spray-drying aerosol vaccines against experimental tuberculosis. This vitamin D-dependent antimicrobial killing mechanism is effective against Mycobacterium tuberculosis and is found in human macrophages, and is unrelated to oxygen or nitrogen radicals. This may explain the greater susceptibility of people of African and Asian descent to tuberculosis.[8]

Professional associations

Current service

Past service

Awards

Publications

  • A relatively complete list of major publications is found at the Dr. Bloom's Harvard Catalyst researcher profile.
  • Bloom, BR, and Bennett B. “Mechanism of a reaction in vitro associated with delayed type hypersensitivity.” Science 153, no. 3731.

External references

References

  1. [1]
    Emrich R, Richter C. (eds.) Profiles in Leadership / AAI Biosketch: An Interview with Dr. Barry Bloom. The American Association of Immunologists website. October 2020. Accessed May 16, 2021
  2. [2]
    "Global Tuberculosis Report".
  3. [3]
    "Board members, US-China Health Summit". Archived from the original on 2017-09-16. Retrieved 2017-09-16.
  4. [4]
    Boston, 677 Huntington Avenue; Ma 02115 +1495‑1000 (2020-11-16). "Coronavirus (COVID-19): Press Conference with Barry Bloom, 11/16/20". News. Retrieved 2020-11-27.{{cite web}}: CS1 maint: numeric names: authors list (link)
  5. [5]
    "Charlie Baker names 17-member coronavirus vaccine advisory group". Boston Herald. 2020-10-11. Retrieved 2020-11-27.
  6. [6]
    Gates Foundation
  7. [7]
    "Grand Challenges in Global Health". Archived from the original on 2014-09-28. Retrieved 2015-08-04.
  8. [8]
    Powell, A. Gates Foundation awards two Harvard investigators $26 million: Grants aim to advance global health. Harvard Gazette, August 25, 2005.
  9. [9]
    "Board members, US-China Health Summit". Archived from the original on 2017-09-16. Retrieved 2017-09-16.
Share this article:

This article uses material from the Wikipedia article Barry_Bloom, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.